Sign in

CIK 0000886163 · Large accelerated filer

LIGAND PHARMACEUTICALS INC

Sign in to watch
Tickers
LGND LGNDZ LGNXZ LGNYZ LGNZZ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
770160744
Phone
858-550-7500
Business address
3911 SORRENTO VALLEY BLVD, SUITE 110, SAN DIEGO, CA, 92121
Former names
LIGAND PHARMACEUTICALS

Securities

  • LGND Common Stock Nasdaq
  • LGNDZ Common stock OTC
  • LGNXZ Common stock OTC
  • LGNYZ Common stock OTC
  • LGNZZ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$6,585,411
in 7 filings, $4.5M under 10b5-1 plans

Net −$6,585,411. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Reardon Andrew −$4.5M CLO & Secretary sold 32% of stake
  2. Aryeh Jason −$1.7M Director sold 5% of stake
  3. Zimmermann Martine −$342K Director sold 24% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-09-04 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise +5,886 $85.79 $505K 47,180
2018-09-04 Berkman Charles S SVP, Gen. Counsel & Secretary Sale −19,417 $254.99 $5.0M 27,763
2018-09-04 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise · Employee Stock Option (right to buy) −7,077 3,292
2018-09-04 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise · Employee Stock Option (right to buy) −5,985 1,931
2018-09-04 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise · Employee Stock Option (right to buy) −5,886 4,577
2018-09-04 Berkman Charles S SVP, Gen. Counsel & Secretary Option exercise · Non-Qualified Stock Option (right to buy) −469 0
2018-09-04 LAMATTINA JOHN L Director Option exercise +3,335 $12.53 $42K 24,784
2018-09-04 LAMATTINA JOHN L Director Sale −3,335 $254.96 $850K 21,449
2018-09-04 LAMATTINA JOHN L Director Option exercise · Non-Qualified Stock Option (right to buy) −3,335 0
2018-08-30 HIGGINS JOHN L Chief Executive Officer Sale −3,500 $258.25 $904K 85,419
2018-08-29 Korenberg Matthew E EVP,Finance & Strategy and CFO Option exercise +11,540 $85.79 $990K 25,099
2018-08-29 Korenberg Matthew E EVP,Finance & Strategy and CFO Sale −18,357 $256.69 $4.7M 6,742
2018-08-29 Korenberg Matthew E EVP,Finance & Strategy and CFO Option exercise · Employee Stock Option (right to buy) −11,540 6,924
2018-08-17 Aryeh Jason Director Sale −26,862 $241.81 $6.5M 51,392
2018-08-17 Davis Todd C Director Sale −3,167 $239.50 $758K 45,056
2018-08-17 HIGGINS JOHN L Chief Executive Officer Option exercise +12,993 $14.47 $188K 101,912
2018-08-17 HIGGINS JOHN L Chief Executive Officer Sale −12,993 $243.00 $3.2M 88,919
2018-08-17 HIGGINS JOHN L Chief Executive Officer Option exercise · Non-Qualified Stock Option (right to buy) −12,993 159,000
2018-08-16 Aryeh Jason Director Sale −1,080 $245.00 $265K 78,254
2018-08-16 Davis Todd C Director Sale −5,833 $239.93 $1.4M 48,223

Page 49 of 55 · 1,097 trades